|Chemical and physical data|
|3D model (Jmol)||
FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is the indazole analogue of XLR-11.
Sweden's public health agency suggested classifying FAB-144 as hazardous substance on November 10, 2014.